Ryan Crisman

Ryan Crisman

Company: Umoja Biopharma

Job title: Co-Founder & Chief Technical Officer


Panel:Reviewing Methods to Editing iPSCs to Increase Therapy Persistence & Cell Retention in vivo 2:00 pm

Discussing how to increase cell survival to produce effective regenerative cell replacement therapies Assessing methods to ensure iPSC therapies for immunology persist long enough for effective tumor killing Does administration of the cell therapy affect retention in the body?Read more

day: Day 1 Track 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.